Indivior plc, of Slough, U.K. said the U.S. Court of Appeals for the Federal Circuit vacated the preliminary injunction previously granted against Dr. Reddy's Laboratories Ltd., of Hyderabad, India, by the U.S. District Court for the District of New Jersey on July 13, 2018, which had prevented Reddy's from selling, offering to sell, or import its generic buprenorphine/naloxone sublingual film product.